EPIMAB BIOTHERAPEUTICS
EpimAb Biotherapeutics is a privately owned biopharmaceutical company dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) platform. Monoclonal antibodies have transformed the treatment of human diseases, including inflammatory and autoimmune diseases, cancer, severe infections and many rare conditions over the course of the past two decades. Bi-specific antibodies are engineered from two different monoclonal antibodies and combine t... heir key features into one molecule. As a novel drug class, bi-specifics provide additional options for the treatment of many life-threatening diseases such as cancer. However, even minor modifications to any pharmaceutically active biologic such as an antibody can significantly change the properties critical to its development, such as its binding properties, the pharmacokinetics, its stability, solubility and the ability to produce it in sufficient quantities at reasonable costs. This challenge has prevented a majority of bi-specific antibodies of potential interest to scientists and clinicians from advancing into clinical development because their drug-like features were compromised. Thus, the need for a new generation of bi-specific antibody therapeutics in the pharmaceutical industry remains high.
EPIMAB BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.epimab.com
Total Employee:
11+
Status:
Active
Contact:
+49 (0) 15226107621
Total Funding:
219 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Apache Apple Mobile Web App Capable DigiCert SSL Apple Mobile Web App Status Bar Style Java EE
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Sio Gene Therapies
Sio Gene Therapies is a clinical-stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hony Capital
Hony Capital investment in Series C - EpimAb Biotherapeutics
Sherpa Venture Capital
Sherpa Venture Capital investment in Series C - EpimAb Biotherapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - EpimAb Biotherapeutics
MiraeAsset Financial Group
MiraeAsset Financial Group investment in Series C - EpimAb Biotherapeutics
SDIC Fund Management
SDIC Fund Management investment in Series C - EpimAb Biotherapeutics
Hidragon Capital
Hidragon Capital investment in Series C - EpimAb Biotherapeutics
CMB International Capital Corporation
CMB International Capital Corporation investment in Series C - EpimAb Biotherapeutics
Decheng Capital
Decheng Capital investment in Series C - EpimAb Biotherapeutics
Adrian Cheng
Adrian Cheng investment in Series C - EpimAb Biotherapeutics
Shangbay Capital
Shangbay Capital investment in Series C - EpimAb Biotherapeutics
Official Site Inspections
http://www.epimab.com
- Host name: 112.65.179.211
- IP address: 112.65.179.211
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai